Assignee
ACTIVE BIOTECH AB
SE37 patents
Top patents by PatentIndex Score
US6875869B2Apr 5, 2005
Process for the manufacture of quinoline derivatives
ACTIVE BIOTECH AB79 citations97
US6395750B1May 28, 2002
Drugs for the treatment of malignant tumors
ACTIVE BIOTECH AB79 citations97
US6077851AJun 20, 2000
Quinoline derivatives
ACTIVE BIOTECH AB139 citations97
US7226595B2Jun 5, 2007
Modified Chimeric superantigens and their use
ACTIVE BIOTECH AB69 citations95
US6605616B1Aug 12, 2003
Quinoline derivatives
ACTIVE BIOTECH AB40 citations95
US6593343B2Jul 15, 2003
Quinoline derivatives
ACTIVE BIOTECH AB60 citations95
US6133285AOct 17, 2000
Quinoline derivatives
ACTIVE BIOTECH AB62 citations95
US6121287ASep 19, 2000
Quinoline derivatives
ACTIVE BIOTECH AB68 citations95
US7763253B2Jul 27, 2010
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
ACTIVE BIOTECH AB63 citations94
US7615225B2Nov 10, 2009
Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen
ACTIVE BIOTECH AB52 citations93
US7125554B2Oct 24, 2006
Engineered superantigen for human therapy
ACTIVE BIOTECH AB71 citations93
US7589208B2Sep 15, 2009
Compositions containing quinoline compounds
ACTIVE BIOTECH AB51 citations91
US7226601B1Jun 5, 2007
Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
ACTIVE BIOTECH AB13 citations82
US7074831B2Jul 11, 2006
Compounds, methods for their preparation and use thereof
ACTIVE BIOTECH AB10 citations71
US9956212B2May 1, 2018
Quinoline carboxamides for use in the treatment of multiple myeloma
ACTIVE BIOTECH AB4 citations68
US11478465B2Oct 25, 2022
Compounds for treatment of eye diseases associated with excessive vascularisation
ACTIVE BIOTECH AB4 citations67
US6642249B2Nov 4, 2003
Immunomodulating compounds
ACTIVE BIOTECH AB8 citations65
US7553849B2Jun 30, 2009
Compounds
ACTIVE BIOTECH AB2 citations62
US11654140B2May 23, 2023
Treatment of ocular inflammatory diseases using laquinimod
ACTIVE BIOTECH AB0 citations58
US6518312B2Feb 11, 2003
Immune enhancement
ACTIVE BIOTECH AB4 citations58
US7081456B2Jul 25, 2006
Immunomodulatory compounds
ACTIVE BIOTECH AB2 citations57
US12208091B2Jan 28, 2025
Compounds for treatment of eye diseases associated with excessive vascularisation
ACTIVE BIOTECH AB0 citations56
US10300053B2May 28, 2019
Quinoline carboxamides for use in the treatment of leukemia
ACTIVE BIOTECH AB1 citations56
US7291612B2Nov 6, 2007
Immunomodulatory compounds
ACTIVE BIOTECH AB2 citations54
US12582643B2Mar 24, 2026
Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy
ACTIVE BIOTECH AB0 citations53
US10385069B2Aug 20, 2019
Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors
ACTIVE BIOTECH AB1 citations53
US7425623B2Sep 16, 2008
Antibody with specificity for colon cancer
ACTIVE BIOTECH AB2 citations51
US7189816B1Mar 13, 2007
Compounds
ACTIVE BIOTECH AB4 citations51
US10314836B2Jun 11, 2019
Quinoline carboxamides for use in the treatment of multiple myeloma
ACTIVE BIOTECH AB0 citations47
US6727062B1Apr 27, 2004
Identification of target structures E.G. in vivo selection method for a phage library
ACTIVE BIOTECH AB3 citations47
US8754104B2Jun 17, 2014
Crystalline salts of quinoline compounds and methods for preparing them
ACTIVE BIOTECH AB0 citations45
US7674906B2Mar 9, 2010
Tetracyclic immunomodulatory compounds
ACTIVE BIOTECH AB0 citations45
US10125125B2Nov 13, 2018
N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors
ACTIVE BIOTECH AB0 citations44
US9873687B2Jan 23, 2018
N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors
ACTIVE BIOTECH AB0 citations44
US12485095B2Dec 2, 2025
Plurality of tasquinimod particles and use thereof
ACTIVE BIOTECH AB0 citations43
US7339059B2Mar 4, 2008
Benzofurans and indols
ACTIVE BIOTECH AB0 citations34
US9771372B2Sep 26, 2017
Compounds useful as S100-inhibitors
ACTIVE BIOTECH AB0 citations30